Effect of ejaculation on serum toal and free prostate-specific antigen concentrations

Urology

Volumn 50, Issue 2, 1997, Pages 239-243

  Herschman, Jonathan D ^a   Smith, Deborah S ^a   Catalona, William J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Urologic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EJACULATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY;

BIOPSY; EJACULATION; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0030855548     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00209-4     Document Type: Article

References (20)

1. Jacobsen SJ, Katusic SK, Bergstralh EJ, Oesterling JE, Ohrt D, Klee GG, Chute CG, and Lieber MM: Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA 274: 1445-1449, 1995.
2. Brawer MK, Chetner MP, Beattie J, Buchner DM, Vessella RL, and Lange PH: Screening for prostatic carcinoma with prostate specific antigen. J Urol 147: 841-845, 1992.
3. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 151: 1283-1290, 1994.
4. Oesterling JE, Rice DC, Glenski WJ, and Bergstralh EJ: Effect of cystoscopy, prostate biopsy and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology 42: 276-282, 1993.
5. Yuan JJ, Coplen DE, Petros JA, Figenshau RS, Ratliff TL, Smith DS, and Catalona WJ: Effects of rectal examination, prostatic massage, ultrasonography, and needle biopsy on serum prostate-specific antigen levels. J Urol 147: 810-814, 1992.
6. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, and Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987.
7. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, and Ratliff TL: Effect of inflammation and benign prostatic hyperplasia on elevated serum prostatic specific antigen levels. J Urol 154: 407-413, 1995.
8. Glenski WJ, Klee GG, Bergstralh EJ, and Oesterling JE: Prostate-specific antigen: establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation, and time on serum concentrations. Prostate 21: 99-110, 1992.
9. Tchetgen MB, Song JT, Strawderman M, Jacobsen SJ, and Oesterling JE: Ejaculation increases the serum prostate-specific antigen concentration. Urology 47: 511-516, 1996.
10. Simak R, Madersbacher S, Zhang ZF, and Maier U: The impact of ejaculation on serum prostate specific antigen. J Urol 150: 895-897, 1993.
11. McAleer JK, Gerson LW, McMahon D, and Geller L: Effect of digital rectal examination (and ejaculation) on serum prostate-specific antigen after twenty-four hours. A randomized, prospective study. Urology 41: 111-112, 1993.
12. Netto NR, Apuzzo F, de Andrade E, Srulzon GB, Cortado PL, and Lima ML: The effects of ejaculation on serum prostate specific antigen. J Urol 155: 1329-1331, 1996.
13. Heidenreich A, Vorreuther R, Neubauer S, Westphal J, Engelmann UH, and Moul JW: The influence of ejaculation on serum levels of prostate specific antigen. J Urol 157: 209-211, 1997.
14. Stenman UH, Leinonen J, Alfthan H, Ranniko S, Tuhkanen K, and Alfthan O: A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
15. Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L, and Leinonen J: Serum concentrations of prostate specific antigen and its complex with alpha-1-antichymotrypsin before diagnosis of prostate cancer. Lancet 344: 1594-1598, 1994.
16. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, and Nadler RB: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274: 1214-1220, 1995.
17. Luderer AA, Chen Y-T, Soriano TF, Kramp WJ, Carlson G, Cuny C, Sharp T, Smith W, Petteway J, Brawer MK, et al: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 46: 187-194, 1995.
18. Smith DS, Bullock AD, Catalona WJ, and Herschman JD: Racial differences in a prostate cancer screening study. J Urol 156: 1366-1369, 1996.
19. Ornstein DK, Rao GS, Smith DS, Ratliff TL, Basler JW, and Catalona WJ: Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels. J Urol 157: 195-198, 1997.
20. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, and Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 270: 860-864, 1993.